Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
US-DASH in Acute Decompensated Heart Failure
NCT07263035Phase 4Recruiting
- Sponsor
- Lakeland Regional Health
- Start
- Apr 2026
- Primary completion
- Jun 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of furosemide in heart failure (HF), sponsored by Lakeland Regional Health. Started Apr 2026; status: recruiting.
02
Drugs
furosemide
03
Conditions
heart failure (HF)
Beyond the preview
Go deeper on NCT07263035.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07263035.